The migration and tube formation of HUVECs treated with CM of BV-treated CRC cells (HCT116 and SW480) with or without inhibitors were examined to further investigate the role of the PI3K/AKT/mTOR signaling pathway in the tumor angiogenesis mediated by BV. The gene discussed is MTOR; the disease is colorectal carcinoma.